Microbot Medical MBOT Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Microbot Medical in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Microbot Medical's investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Microbot Medical's investing cash flow?
- Microbot Medical (MBOT) reported investing cash flow of $5M in Q1 2026.
- How has Microbot Medical's investing cash flow changed year-over-year?
- Microbot Medical's investing cash flow increased by 120.1% year-over-year, from -$24.83M to $5M.
- What is the long-term trend for Microbot Medical's investing cash flow?
- Over 2 years (2022 to 2025), Microbot Medical's investing cash flow has grown at a 334.4% compound annual growth rate (CAGR), from -$3.84M to -$72.38M.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.